13-Methyltetradecanoic Acid Exhibits Anti-Tumor Activity on T-Cell Lymphomas In Vitro and In Vivo by Down-Regulating p-AKT and Activating Caspase-3
Figure 1
Inhibition of proliferation of Jurkat, Hut78 and EL4 cells by 13-MTD treatment.
(A) Cultivation with 13-MTD for 48 hours at different concentrations (10, 20, 40, 60, 80 µg/ml) inhibited the proliferation of Jurkat, Hut78 and EL4 cells in a dose-dependent manner. (B) Cell viability of 13-MTD-treated Jurkat cells decreased in a time-dependent manner at different incubation time points (24, 48, 72 h).